Explore: Autologous Transplantation

Autologous stem-cell transplantation (also called autogenous, autogenic, or autogenic stem-cell transplantation and abbreviated auto-SCT) is the autologous

Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral

meaning "self" in Greek). The autologous tissue (also called autogenous, autogeneic, or autogenic tissue) transplanted by such a procedure is called an

term fecal microbiota transplantation. Cultured intestinal bacteria are being studied as an alternative to fecal microbiota transplant. One example is the

returned to patient a few days later. This approach, termed autologous bone marrow transplantation, was initially thought to be of benefit to a wide group

hematopoietic stem cell transplantation. This usually takes the form of a bone marrow or peripheral blood stem cell transplantation, but the cells can also

involved giving cord blood back to the donor, a practice known as autologous transplantation and the chief selling point for private cord-blood banking. Private

marrow transplants in the US. For a long time, bone marrow transplantation was the only clinically applicable method of cell transplantation, however

free flap, free autologous tissue transfer and microvascular free tissue transfer are synonymous terms used to describe the "transplantation" of tissue from

healing properly, an autologous skin graft is the best option, to prevent rejection of the tissue. Since autologous transplantation cannot always be performed